3D Bioprinting is described as an additive manufacturing technique that uses cells and other biocompatible materials that are also known as bioinks, to print tissue or living structures layer-by-layer which mimic the behavior of natural living systems. 3D bioprinting has developed as an encouraging new approach for fabricating complex biological constructs in the field of tissue engineering and regenerative medicine. It aims to alleviate the hurdles of conventional tissue engineering methods by precise and controlled layer-by-layer assembly of biomaterials in a desired 3D pattern.
Bioengineering techniques for the construction of artificial blood vessels have been studied by several research organizations. Successful tissue regeneration has been associated with the seeding of cells, the scaffolds and the construction technologies. 3D printing and electrospinning technologies can promote the rapid and accurate fabrication of scaffolds for cellularization with vascular progenitors or mixtures of mature human vascular cells to yield bioengineered blood vessels. The progress in 3D bioprinting is driven by the increasing need for alternative construction approaches to develop tissues and even organs, since the available conventional methods are not capable of fabricating materials and constructs with the necessary structural, mechanical and biological properties such as biocompatibility and complexity.
ALSO READ : http://www.marketwatch.com/story/3d-bioprinting-of-living-human-tis...
The growing demand for the organ transplantation coupled with the limited numbers of donor across the globe is leading to the growing demand for 3D bio printed living human tissue market. As per a report, more than 120,000 people in the US alone are on waiting lists for organs, and others experience chronic problems due to the long-term damaging effects of post-transplant immunosuppression. So, there’re is growing need for an alternative to the organ transplant waiting list. Moreover, the scientific community has already succeeded in bringing together multidisciplinary teams of researchers, physicians, and engineers to take on the biggest challenges to human health, and 3D bioprinting is an exciting new tool with the potential to eliminate the organ transplant waiting list.
Based on technology, the market is fragmented into inkjet, Extrusion, laser assisted bioprinting and Others. The extrusion segment generated revenue of USD 372.8 million in 2019. The market is expected to grow at a CAGR of 21.3% during the forecast period to reach a market valuation of USD 1,688.4 million by 2027 owing to the benefits such as ability to fabricate designs with high cell densities and great versatilities.
ALSO READ : http://www.marketwatch.com/story/microfilm-equipment-market-researc...
For a better understanding of the market penetration of the 3D Bioprinting of Living Human Tissues/Organs Market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, and Rest of APAC), and Rest of World. North America constitutes a major market for the 3D Bioprinting of Living Human Tissues/Organs Market industry and generated revenue of USD 235.4 million in 2019 owing to the increasing demand for the organ transplant coupled with the limited number of donors. Also, a rise in funding for R&D activities associated with 3D Bioprinting of Living Human Tissues/Organs Market is acting as a growth catalyst to the industry. Some of the major players operating in the market include 3Dynamic Systems, Aether, Aspect Biosystems, BioBots (now Allevi), BioDan Group, BIOLIFE4D, Cellbrick, Cellenion, Cellink, Digilab, GeSiM, Microdrop Technologies, MicroFab Technologies, Organovo. Several M&A’s along with partnerships have been undertaken by these players to develop 3D Bioprinting of Living Human Tissues/Organs Market
ALSO READ : http://www.marketwatch.com/story/pneumatic-chisels-market-research-...
The global 3D Bioprinting of Living Human Tissues/Organs Market was valued at USD 651.6 million in 2019 and is projected to expand significantly with a CAGR of 20.7% from 2021-2027F. The global 3D Bioprinting of Living Human Tissues/Organs Market is expected to witness a boost, owing to the increasingly aging population with chronic respiratory disease, Rising R&D investment, technological advancement, emerging cases of COVID-19, etc.,
Table of Contents
1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global 3D Bioprinting of Living Human Tissues/Organs Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global 3D Bioprinting of Living Human Tissues/Organs Market
2.1.1 Main Objective of the Global 3D Bioprinting of Living Human Tissues/Organs Market
3 INDUSTRY PERFORMANCE
4 EXECUTIVE SUMMARY
5 CASE STUDIES
6 COVID-19 IMPACT
7 MARKET INSIGHTS BY TECHNOLOGY
7.1 Inkjet
7.2 Extrusion
7.3 Laser Assisted Bioprinting
7.4 Others
8 MARKET INSIGHTS BY APPLICATION
8.1 Research
8.2 Clinical
9 MARKET INSIGHTS BY MATERIAL
9.1 Collagen
9.2 Gelatine
9.3 Alginate
9.4 Synthetic Macromolecules
9.5 Hyaluronic Acid
9.6 Generic Hydroge
9.7 Others
10 MARKET INSIGHTS BY TISSUE TYPE
10.1 Generic Tissue / Organ
10.2 Renal
10.3 Skin
10.4 Bone
10.5 Liver
10.6 Lungs
10.7 Cardiac / Cardiovascular
10.8 Adipose Tissue
10.9 Cartilage
10.10 Ocular Tissue
10.11 Tumour Tissue
10.12 Others
11 MARKET INSIGHTS BY END-USER
11.1 Hospitals
11.2 Research Organizations & Academic Institutes
12 MARKET INSIGHTS BY REGION
12.1 North America 3D Bioprinting of Living Human Tissues/Organs Market
12.1.1 United States
12.1.2 Canada
12.1.3 Rest of North America
12.2 Europe 3D Bioprinting of Living Human Tissues/Organs Market
12.2.1 Germany
12.2.2 France
12.2.3 United Kingdom
12.2.4 Spain
12.2.5 Rest of Europe
12.3 Asia Pacific 3D Bioprinting of Living Human Tissues/Organs Market
12.3.1 China
12.3.2 Japan
12.3.3 India
12.3.4 Australia
12.3.5 Rest of Asia Pacific
12.4 Rest of the World 3D Bioprinting of Living Human Tissues/Organs Market
13 3D Bioprinting of Living Human Tissues/Organs MARKET DYNAMICS
13.1 Market Trends & Drivers
13.2 Market Challenges
13.3 Impact Analysis
14 LEGAL & REGULATORY FRAMEWORK
15 DEMAND AND SUPPLY SIDE ANALYSIS
15.1 Demand Side Analysis
15.2 Supply Side Analysis
15.2.1 Top Product Launches
15.2.2 Top Business Partnerships
15.2.3 Top Merger & Acquisitions
15.2.4 Top Business Expansions and Investments
16 VALUE CHAIN ANALYSIS
17 3D BIOPRINTING OF LIVING HUMAN TISSUES/ORGANS MARKET HOTSPOT & OPPORTUNITIES
18 3D BIOPRINTING OF LIVING HUMAN TISSUES/ORGANS MARKET TRENDS & INSIGHTS
19 COMPETITIVE SCENARIO
19.1 Porter’s Five forces analysis
19.1.1 Bargaining power of Supplier
19.1.2 Bargaining power of Buyer
19.1.3 Industry Rivalry
19.1.4 Availability of Substitute
19.1.5 Threat of new Entrants
20 COMPANY PROFILED
20.1 Allevi
20.2 Aspect Biosystems
20.3 BioDan Group
20.4 Biolife4D
20.5 Cellbricks GmbH
20.6 Cellink
20.7 Digilab
20.8 GeSiM
20.9 Microdrop Technologies
20.10 MicroFab Technologies
21 DISCLAIMER ----
..…..continued
CONTACT DETAILS :
[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105